CIK 0001711754 · Non-accelerated filer<br>Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 475205835
- Phone
- 8589643720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Clark Ronnie Duane Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2026-09-15 | SAPIRSTEIN JAMES Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2026-07-02 | Juda Scott Director | Option exercise | +14,801 | $1.40 | $21K | 86,404 |
| 2026-07-02 | Juda Scott Director | Option exercise · Common Stock Purchase Warrant | −14,801 | $0.13 | $2K | 14,802 |
| 2026-07-02 | Lowdell Mark William Chief Scientific Officer | Option exercise | +7,211 | $1.40 | $10K | 1,518,017 |
| 2026-07-02 | Lowdell Mark William Chief Scientific Officer | Option exercise · Common Stock Purchase Warrant | −7,211 | $0.13 | $901 | 7,212 |
| 2026-07-02 | Moss David J Chief Executive Officer | Option exercise | +9,014 | $1.40 | $13K | 1,294,883 |
| 2026-07-02 | Moss David J Chief Executive Officer | Option exercise · Common Stock Purchase Warrant | −9,014 | $0.13 | $1K | 9,014 |
| 2025-12-01 | Moss David J Chief Executive Officer | Grant or award · Option (right to buy) | +750,000 | 750,000 | ||
| 2025-12-01 | Lowdell Mark William Chief Scientific Officer | Grant or award · Option (right to buy) | +600,000 | 600,000 | ||
| 2025-12-01 | Ellspermann Cory Randall CFO | Grant or award · Option (right to buy) | +300,000 | 300,000 | ||
| 2025-12-01 | Schroeder Timothy j Director | Grant or award · Option (right to buy) | +150,000 | 150,000 | ||
| 2025-12-01 | Juda Scott Director | Grant or award · Option (right to buy) | +150,000 | 150,000 | ||
| 2025-12-01 | Ganjei James Kelly Director | Grant or award · Option (right to buy) | +150,000 | 150,000 | ||
| 2025-12-01 | ALLEN MARCIA Director | Grant or award · Option (right to buy) | +150,000 | 150,000 | ||
| 2025-11-18 | Schroeder Timothy j Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 | ||
| 2025-11-18 | Schroeder Timothy j Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Schroeder Timothy j Director | Returned to the company · Stock Option (right to buy) | −108,000 | 0 | ||
| 2025-11-18 | Schroeder Timothy j Director | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2025-11-18 | Schroeder Timothy j Director | Returned to the company · Stock Option (right to buy) | −15,975 | 0 |
Page 1 of 11 · 216 trades